Peptide Therapy for Weight Loss
Weight loss is long and rarely linear, and it is hardest when the conventional approaches have already been tried. A physician-supervised peptide protocol is one framework for working on appetite regulation and metabolic function while protecting muscle mass.
What is peptide therapy for weight loss?
Interest in peptides for weight management has grown alongside GLP-1 receptor agonists such as semaglutide. These compounds act on pathways involved in glucose metabolism, appetite signaling and the body's energy balance.
The difference from a generic weight-loss prescription is the selection. Which peptide, at what dose, follows from your medical history, body composition and metabolic labs rather than from a default.
How do peptides for weight loss work?
They act on the neurological and endocrine pathways that govern appetite and glucose metabolism. Semaglutide, for example, binds GLP-1 receptors in the pancreas and suppresses glucagon release. Because it mimics the GLP-1 hormone, it also acts on receptors in the hypothalamus and brainstem, which is where the reduction in hunger comes from.
The clinical literature is substantial. In the STEP 1 trial, published in the New England Journal of Medicine in 2021, 86% of participants taking weekly semaglutide 2.4 mg lost at least 5% of their body weight.[1]
What it is studied to support
- Reduced food cravings
- Increased satiety
- Lower caloric intake as a downstream effect
- Metabolic markers and cardiovascular health
- Slower gastric emptying
Peptide options
Below is the landscape rather than a menu. Which of these is appropriate for any individual, if any, is a clinical decision, and several are studied far more thoroughly than others.
Tirzepatide
A dual agonist at both GIP and GLP-1 receptors. Where earlier compounds targeted GLP-1 alone, tirzepatide engages both, enhancing glucose-dependent insulin release and suppressing glucagon secretion. In SURMOUNT-1, published in the New England Journal of Medicine in 2022, participants on the 15 mg dose saw mean body weight reduction of up to 20.9% over 72 weeks.[2]
Semaglutide
The GLP-1 receptor agonist most of the clinical literature is built on, and the reference point the newer compounds are measured against. Binds GLP-1 receptors in the pancreas and, via receptors in the hypothalamus and brainstem, reduces hunger.
Retatrutide
A triple agonist, adding the glucagon receptor to GIP and GLP-1. The addition is intended to raise energy expenditure alongside the appetite effects of the other two pathways. Trial data is more recent and thinner than for semaglutide or tirzepatide.
Orforglipron
An oral GLP-1 receptor agonist rather than an injectable, which for some people is the difference between starting and not starting. Small-molecule rather than peptide-based, so it does not require the same handling.
Cagrilintide with a GLP agonist
Cagrilintide is a long-acting amylin analog, studied in combination with GLP-1 agonists rather than alone. Amylin acts on satiety through a separate pathway, and the interest is in whether pairing the two does more than either does by itself.
AOD-9604
A fragment of human growth hormone, specifically the portion studied for fat metabolism without the growth-promoting effects of the whole molecule. Human evidence is limited and considerably weaker than the incretin literature.
5-Amino-1MQ
An NNMT inhibitor, studied in the context of fat cell metabolism and cellular energy rather than appetite. A different mechanism entirely from the GLP class, and at a much earlier stage of research.
MOTS-c
A 16-amino-acid peptide encoded in mitochondrial DNA, studied for its role in metabolic homeostasis and cellular energy regulation, acting on the AMPK pathway. Earlier stage than the GLP-1 literature.
Tesamorelin
A growth hormone releasing hormone analog, studied specifically in the context of visceral adipose tissue rather than total body weight. A different target from the appetite-led compounds above.
Related goals
- Reductions in excess body fat
- Appetite control
- Preserving muscle mass during a calorie deficit
- Working through a weight-loss plateau
- Long-term weight maintenance
Questions
What are the best peptides for weight loss?
There is no single best one. The appropriate choice depends on your goals, your medical history and what your labs show.
How long does peptide therapy for weight loss take to work?
It varies. Changes in appetite are often noticed within the first few weeks; changes in weight develop over months.
Are peptide injections for weight loss right for everyone?
No. Eligibility depends on your medical profile, existing conditions and any medications you already take. That is what the physician review is for.
References
If you want to go further
None of the above is a recommendation, and which compound suits a person is a clinical question rather than a shopping one. If you want that answered properly, LongevityPlan runs physician-supervised programs: an examination by a licensed physician first, then a protocol adjusted over time against your own labs.
Other goals
Muscle growth
Physician-supervised peptide therapy studied for muscle protein synthesis, recovery and strength development, personalized to your labs and training.
Healthy aging
Physician-supervised peptide therapy studied for cellular repair, mitochondrial function and the visible signs of aging, as part of a longevity protocol.
Peptide therapy through LongevityPlan is prescribed and supervised by licensed physicians. Nothing on this page is medical advice, and no outcome is guaranteed. Whether any protocol is appropriate for you is a decision made with a clinician after review of your history and labs.